Lytic vs. Lysogenic Cycles

SECTION 1

Historical Context & Motivation

The study of viruses that infect bacteria—bacteriophages—ranks among the most consequential threads in twentieth-century biology. Before molecular biology possessed the tools to visualize DNA or decode gene expression, phage researchers were already revealing that hereditary information could be carried by nucleic acid, that gene regulation follows logical switches, and that viral genomes could quietly integrate into host chromosomes. The distinction between a lytic cycle, in which the phage rapidly replicates and destroys its host, and a lysogenic cycle, in which viral DNA integrates into the bacterial chromosome and replicates passively with the host, became a foundational framework for understanding not only phage biology but also oncogenic viruses, CRISPR-Cas immunity, and modern phage therapy.

1915–1917

Discovery of Bacteriophages

Frederick Twort and Félix d'Hérelle independently observe transmissible lysis of bacterial cultures, establishing that a filterable agent—later called a bacteriophage—can destroy bacteria.

1950

Lwoff Defines Lysogeny

André Lwoff demonstrates that certain phages exist as prophages within the bacterial chromosome, replicating silently until induced by UV light or chemical stress. This work earns him a share of the 1965 Nobel Prize.

1953

Hershey–Chase Experiment

Alfred Hershey and Martha Chase use radiolabeled phage T2 to prove that DNA, not protein, is the genetic material injected into host cells during the lytic cycle—a landmark in molecular biology.

1967

Lambda Phage Regulation Elucidated

Mark Ptashne and colleagues characterize the CI repressor and Cro protein of phage λ, revealing the genetic switch that governs the decision between lysis and lysogeny—a paradigm for gene regulation.

2012–Present

CRISPR & Phage Therapy Renaissance

Understanding of lysogeny informs the discovery that CRISPR-Cas systems are bacterial immune memories of past phage infections. Simultaneously, rising antibiotic resistance revives interest in lytic phages as therapeutic agents.

A central question thus emerged from this historical arc: when a phage infects a bacterium, what determines whether the virus immediately destroys its host or instead integrates its genome and waits? This question motivates the comparative study of the lytic and lysogenic pathways—two fundamentally different survival strategies encoded within the same viral genome.

SECTION 2

Core Principles & Definitions

Before dissecting each cycle in detail, it is essential to establish the key concepts that underpin bacteriophage replication strategies. All phages begin infection the same way—by adsorbing to the host cell surface and injecting their nucleic acid—but diverge dramatically in what happens next. Virulent phages (such as T4) are obligately lytic; they always destroy the host. Temperate phages (such as λ) possess the genetic circuitry to choose between the lytic and lysogenic pathways depending on environmental and host conditions. The following core ideas frame this decision.

Lytic Cycle

The phage hijacks host biosynthetic machinery to replicate its genome and assemble new virions. Host cell lysis releases progeny phages (the burst) into the environment, killing the bacterium.

Lysogenic Cycle

The phage integrates its genome into the host chromosome (or exists as a stable plasmid), forming a prophage. The prophage replicates passively each time the bacterium divides, without producing virions.

Prophage Induction

Under stress (UV damage, nutrient starvation, SOS response), the prophage excises from the host chromosome and enters the lytic cycle. This switch is mediated by degradation of the CI repressor in phage λ.

Lysogenic Conversion

Prophage genes can alter host phenotype—conferring toxin production (e.g., Shiga toxin in E. coli, diphtheria toxin in C. diphtheriae), antibiotic resistance, or superinfection immunity.

Lysis–Lysogeny Decision

In temperate phages, a molecular switch (the CI/Cro genetic toggle in λ) integrates signals about host health, multiplicity of infection, and nutrient availability to commit the phage to one pathway.

✦ KEY TAKEAWAY

Think of a temperate phage as an employee who can either raid the supply closet and leave immediately (lytic) or embed as a sleeper agent within the company (lysogenic), quietly copying itself with every company expansion until a crisis triggers it to act. Virulent phages, by contrast, are always raiders—they lack the genetic toolkit for covert integration.

SECTION 3

Visual Overview of Both Cycles

The diagram compares the five stages of the lytic pathway (left) with the lysogenic pathway (right). Both begin with adsorption and DNA injection but diverge immediately afterward. The dashed arrow from induction (pink) to lysis illustrates that a prophage can exit lysogeny and enter the lytic cycle upon stress-induced SOS activation.

As the diagram illustrates, both pathways share the initial step of adsorption and nucleic acid injection, during which the phage recognizes specific surface receptors on the bacterial cell and transfers its genome into the cytoplasm. In the lytic pathway (left column), the phage genome commandeers host ribosomes, polymerases, and metabolites to mass-produce viral components, which are assembled into complete virions before lysis ruptures the cell membrane. In the lysogenic pathway (right column), the phage-encoded integrase catalyzes site-specific recombination, inserting the phage genome into the host chromosome at a defined attachment site (attB/attP in phage λ). The resulting prophage is maintained by the CI repressor, which silences lytic promoters. Crucially, the prophage state is not irreversible: environmental stress can degrade CI and trigger prophage induction, channeling the phage back into lytic replication.

SECTION 4

Molecular Mechanism — The Lambda Genetic Switch

The best-characterized model for the lysis–lysogeny decision is the genetic switch of bacteriophage λ (lambda). After injection, the linear λ genome circularizes, and transcription from two competing promoters—P_R and P_RM—determines the phage's fate. The outcome hinges on a molecular competition between two regulatory proteins: CI repressor (favoring lysogeny) and Cro protein (favoring lysis). Both proteins bind to the same operator regions (O_R1, O_R2, O_R3) but with different binding affinities and in opposite order of preference, creating a bistable toggle switch.

Key Molecular Players

Major regulatory components of the phage λ genetic switch

Component	Function	Pathway Favored
CI Repressor	Binds O_R1 and O_R2 cooperatively; represses P_R and activates P_RM	Lysogeny
Cro Protein	Binds O_R3 first; represses P_RM → blocks CI synthesis	Lysis
CII & CIII	CII activates transcription from P_RE and P_I (integrase promoter); CIII stabilizes CII against FtsH protease	Lysogeny
N & Q Anti-terminators	Allow read-through of transcription terminators, enabling expression of replication, recombination, and late lytic genes	Lysis
RecA (host)	Activated during SOS response; stimulates CI auto-cleavage, derepressing lytic genes and triggering prophage induction	Induction (lytic)

The decision circuit can be understood as a bistable genetic toggle. When the multiplicity of infection (MOI) is high and the host is nutrient-replete, elevated CII levels drive integrase expression and CI production, establishing lysogeny. Conversely, when MOI is low or the host is stressed, CII is degraded by FtsH protease, Cro accumulates, and the phage commits to lytic development. The cooperativity of CI binding to O_R1–O_R2 ensures a sharp, switch-like transition rather than a gradual one—a design principle also found in eukaryotic cell-fate decisions.

BURST SIZE

B = (Number of phage released) / (Number of infected cells)

The burst size (B) quantifies lytic productivity. For phage T4, B ≈ 100–200; for λ in lytic mode, B ≈ 50–100. This parameter is experimentally determined via one-step growth curves.

LYSOGENIZATION FREQUENCY

f(lysogeny) = Lysogens / (Lysogens + Lytic plaques)

The lysogenization frequency measures the proportion of infections resulting in lysogeny under defined conditions. For λ at MOI ≈ 1 and 37 °C in rich media, f ≈ 0.01–0.05; at high MOI or under starvation, f can approach 1.0.

SECTION 5

Detailed Breakdown of Each Cycle Stage

To fully appreciate the differences between the lytic and lysogenic pathways, it is instructive to examine each stage in molecular detail. The following table compares corresponding events across both cycles, highlighting where the pathways diverge and where they share common mechanisms.

Stage-by-stage comparison of the lytic and lysogenic cycles

Stage	Lytic Cycle	Lysogenic Cycle
1. Attachment	Phage tail fibers bind to specific receptors (e.g., LamB for λ, OmpC for T4). This step is identical in both pathways.	Same as lytic—receptor specificity determines host range regardless of subsequent pathway.
2. Penetration	Linear dsDNA is injected through the phage tail; capsid remains outside. For T4, lysozyme in the baseplate locally digests peptidoglycan.	Identical injection mechanism. The injected λ DNA circularizes via cohesive (cos) ends.
3. Biosynthesis / Integration	Host DNA is degraded (T4 uses nucleases); phage DNA replication begins via rolling-circle or bidirectional θ-replication. Early, middle, and late gene expression cascades are activated by anti-termination (N, Q proteins in λ).	CII activates P_I → integrase expression. Int protein catalyzes site-specific recombination between attP (phage) and attB (bacterial) sites, inserting λ genome between gal and bio operons in E. coli.
4. Assembly / Maintenance	Capsid proteins self-assemble; concatemeric DNA is packaged by the terminase complex (cos-site or headful packaging). Tail fibers and baseplates are added.	No virion assembly occurs. CI repressor maintains prophage silence. Superinfection immunity prevents re-infection by related phages. Prophage replicates as part of the chromosome.
5. Release / Induction	Holin proteins form pores in the inner membrane; endolysin degrades peptidoglycan → osmotic lysis releases 50–200 progeny phages.	SOS response activates RecA → stimulates CI autocleavage → excisionase + integrase excise prophage → phage enters lytic cycle.

This diagram depicts the reversible integration of phage λ DNA into the E. coli chromosome. Integration is catalyzed by Int and IHF proteins at the attP/attB sites, while excision requires both Xis and Int. The bottom bar shows the linear gene map with key lytic and lysogenic regulatory genes color-coded.

The integration event is a model of site-specific recombination. The λ integrase (Int) belongs to the tyrosine recombinase family and catalyzes strand exchange between the phage attachment site (attP, ~240 bp) and the bacterial attachment site (attB, ~25 bp), with the accessory factor IHF (integration host factor) bending the DNA to juxtapose the core sequences. The resulting prophage is flanked by hybrid sites attL and attR. Excision is not simply the reverse reaction; it requires an additional phage protein, excisionase (Xis), which remodels the recombinogenic complex to favor attL × attR recombination. This directionality—integration catalyzed by Int + IHF alone, excision requiring Xis + Int + IHF—ensures that a stably integrated prophage does not spontaneously excise under normal growth conditions.

SECTION 6

Worked Example — One-Step Growth Curve Analysis

A classic experiment in phage biology is the one-step growth curve, first developed by Ellis and Delbrück (1939). This experiment measures the burst size and latent period of a lytic phage by synchronizing infection and tracking plaque-forming units (PFU) over time. The following example walks through the quantitative analysis.

Determining Burst Size from a One-Step Growth Experiment

Step 1 — Identify Given ValuesA culture of E. coli B (10⁸ cells/mL) is infected with phage T4 at a multiplicity of infection (MOI) of 0.1. After a 5-minute adsorption period, unadsorbed phages are removed by dilution and anti-phage serum. At time zero (post-adsorption), the titer is 1.0 × 10⁷ PFU/mL. After the burst (t = 30 min), the titer rises to 1.5 × 10⁹ PFU/mL.

Initial PFU = 1.0 × 10⁷ mL⁻¹; Final PFU = 1.5 × 10⁹ mL⁻¹

Step 2 — Calculate the Number of Infected CellsAt MOI = 0.1 with 10⁸ cells/mL, the number of infecting phages equals MOI × cell concentration = 0.1 × 10⁸ = 1.0 × 10⁷ phages/mL. At low MOI, we assume each phage infects a different cell, so the number of infected cells ≈ 1.0 × 10⁷ cells/mL. This matches the initial PFU reading because each infective center produces one plaque.

Infected cells ≈ 1.0 × 10⁷ mL⁻¹

Step 3 — Apply the Burst Size FormulaBurst size (B) is defined as the ratio of phage progeny released to the number of infected cells: B = (Final PFU) / (Initial infective centers) = (1.5 × 10⁹) / (1.0 × 10⁷).

B = 150 phages per infected cell

Step 4 — Interpret the Latent PeriodThe PFU count remained constant from t = 0 to approximately t = 22 min (the latent period), during which phages were replicating intracellularly but no free phages were released. The rise period (t ≈ 22–30 min) corresponds to the asynchronous lysis of individual infected cells. These parameters—latent period, rise period, and burst size—collectively define the lytic replication kinetics of a phage.

Latent period ≈ 22 min; Rise period ≈ 8 min; Burst size = 150

SECTION 7

Comparative Advantages & Ecological Significance

Why would natural selection favor a temperate phage that can choose lysogeny over an obligately lytic phage that maximizes immediate progeny output? The answer lies in evolutionary trade-offs. Lytic replication is advantageous when susceptible hosts are abundant and conditions favor rapid propagation—a strategy akin to r-selection in ecology. Lysogeny, by contrast, is advantageous when hosts are scarce, the environment is harsh, or the phage benefits from 'hitchhiking' on a growing bacterial population until conditions improve. The following table outlines the key trade-offs between these strategies.

Comparative features of the lytic and lysogenic strategies

Feature	Lytic Cycle	Lysogenic Cycle
Host outcome	Immediate cell death via lysis	Host survives; prophage confers immunity to superinfection
Progeny production	Rapid; 50–200 phages released per cell within 20–60 min	None until induction; prophage copies increase with host division
Genome replication	Independent of host chromosome; high-copy rolling circle or θ replication	Passive; replicated once per cell division as part of the chromosome
Environmental trigger	Default for virulent phages; occurs in temperate phages when CII is unstable	Favored by high MOI, nutrient limitation, and high CII/CIII activity
Host gene transfer	Generalized transduction possible (headful packaging errors)	Specialized transduction (aberrant excision carries flanking host genes)
Clinical relevance	Phage therapy exploits strictly lytic phages to kill pathogenic bacteria	Lysogenic conversion can produce virulence factors (toxins, adhesins)

✦ KEY TAKEAWAY

In ecology, organisms evolve to exploit abundant resources aggressively or to conserve and persist when resources are scarce. Temperate phages embody both strategies in a single genome: the lytic cycle is an aggressive 'boom' strategy that maximizes short-term reproduction, while the lysogenic cycle is a conservative 'bank' strategy—depositing the viral genome in a host cell that will replicate it indefinitely, with the option to 'withdraw' when conditions change. This duality is analogous to a venture capital firm that can either cash out quickly or retain equity in a growing company.

SECTION 8

Connections to Advanced Virology & Medicine

The lytic–lysogenic paradigm extends well beyond bacteriophages. In eukaryotic virology, analogous strategies are exhibited by retroviruses (HIV integrates as a provirus), herpesviruses (establish latency in neurons or lymphocytes), and tumor viruses (HPV can integrate into host chromosomes, disrupting regulatory genes). Understanding the molecular logic of the lambda switch has provided conceptual tools that inform research on viral latency, reactivation, oncogenesis, and gene therapy vector design.

Bridging phage biology to eukaryotic virology and biotechnology

Concept	Phage Biology (This Lesson)	Advanced / Eukaryotic Virology
Genome integration	λ integrase (tyrosine recombinase) inserts DNA at attB via site-specific recombination	HIV integrase inserts proviral DNA semi-randomly; used in lentiviral gene therapy vectors
Latency maintenance	CI repressor silences lytic genes; positive autoregulation ensures stable lysogeny	Herpesvirus latency-associated transcripts (LATs) suppress lytic gene expression; HIV latency involves epigenetic silencing
Reactivation	SOS response → RecA* → CI cleavage → prophage induction	Stress, immunosuppression, or T-cell activation reactivates latent HIV or herpes simplex virus
Host phenotype alteration	Lysogenic conversion: prophage-encoded toxins (cholera toxin, diphtheria toxin)	HPV E6/E7 oncoproteins degrade p53 and Rb → cervical carcinoma; insertional mutagenesis
CRISPR connection	Spacer sequences in CRISPR arrays are derived from past lytic/lysogenic phage infections	CRISPR-Cas9 genome editing technology adapted from this bacterial immune system

The resurgence of phage therapy in the era of antibiotic resistance underscores the practical importance of distinguishing lytic from lysogenic phages. Therapeutic applications preferentially use strictly lytic (virulent) phages because temperate phages risk horizontal gene transfer of virulence or resistance determinants via lysogenic conversion or specialized transduction. Engineering temperate phages into obligately lytic variants—by deleting CI and int genes—is an active area of synthetic biology research that directly draws upon the molecular mechanisms discussed in this lesson.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

A bacteriophage that can only replicate via the lytic cycle is termed a virulent phage, whereas one capable of both lytic and lysogenic replication is termed temperate. Explain why a clinician designing a phage therapy cocktail against a multidrug-resistant pathogen would preferentially select virulent phages over temperate ones.

PROBLEM 2 — BASIC CALCULATION

In a one-step growth experiment, 2.0 × 10⁶ cells were infected at an MOI of 0.05. After lysis, the total PFU count was 1.2 × 10⁷. Calculate the burst size.

PROBLEM 3 — INTERMEDIATE

A researcher UV-irradiates a lysogenic strain of E. coli (λ) and observes a 50-fold increase in PFU after 90 minutes. Another aliquot of the same culture, treated with a RecA inhibitor before UV exposure, shows no increase in PFU. Explain these observations in terms of the molecular mechanism of prophage induction.

PROBLEM 4 — APPLIED

Corynebacterium diphtheriae causes diphtheria only when lysogenized by phage β, which carries the tox gene encoding diphtheria toxin. A non-lysogenic strain is avirulent. If you isolated a clinical strain producing diphtheria toxin, describe two experimental approaches you would use to confirm that the toxin gene is prophage-encoded rather than chromosomally encoded.

PROBLEM 5 — CRITICAL THINKING

The lysis–lysogeny decision in phage λ has been modeled as a bistable genetic switch governed by mutual repression between CI and Cro. However, recent single-cell studies suggest that the decision also involves stochastic fluctuations in CII concentration. Discuss how stochasticity at the single-cell level can produce a deterministic-looking population outcome, and propose an experimental design using fluorescent reporters to quantify the contribution of noise versus deterministic regulation in the lysis–lysogeny decision.

SUMMARY

Lesson Summary

Bacteriophages replicate through two fundamentally distinct pathways. The lytic cycle involves phage adsorption, DNA injection, host machinery hijacking, virion assembly, and cell lysis, releasing 50–200 progeny phages within minutes. The lysogenic cycle instead uses integrase to insert the phage genome into the host chromosome as a prophage, which is maintained silently by the CI repressor and replicated passively with each bacterial division. Virulent phages are obligately lytic, while temperate phages can choose either pathway.

The lysis–lysogeny decision in phage λ is governed by a bistable genetic switch: the CI repressor promotes lysogeny while the Cro protein promotes lysis. Environmental stress activates the SOS response, triggering RecA-mediated CI cleavage and prophage induction. This framework has far-reaching implications: lysogenic conversion underlies major bacterial diseases (diphtheria, cholera, Shiga toxin-producing E. coli), CRISPR-Cas immunity evolved from bacterial defenses against phage infection, and modern phage therapy exploits strictly lytic phages to combat antibiotic-resistant infections.